During the past decade, UMHAT "Sv. Georgi", EAD conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 29 clinical trials were completed, i.e. on average, 69% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 17 clinical trials were completed. i.e. 94.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMHAT "Sv. Georgi", EAD" #1 sponsor was "Bayer" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Baxalta now part of Shire" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT "Sv. Georgi", EAD" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "UMHAT "Sv. Georgi", EAD" are "Hemophilia A" (4 trials), "Ulcerative Colitis" (3 trials), "Atrial Fibrillation" (2 trials), "Bipolar Disorder" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "UMHAT "Sv. Georgi", EAD" in a lesser frequency.

Most popular intervention types in "UMHAT "Sv. Georgi", EAD" are "Drug" (44 trials), "Biological" (9 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Rituximab" (3 trials), "Standard of Care" (3 trials), "Bendamustine" (2 trials) and "Cariprazine" (2 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT "Sv. Georgi", EAD" are 50 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "UMHAT "Sv. Georgi", EAD". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in UMHAT "Sv. Georgi", EAD, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT "Sv. Georgi", EAD, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".